Evaxion A/S Files July 2025 6-K Report

Ticker: EVAX · Form: 6-K · Filed: Jul 25, 2025 · CIK: 1828253

Evaxion A/S 6-K Filing Summary
FieldDetail
CompanyEvaxion A/S (EVAX)
Form Type6-K
Filed DateJul 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, sec-filing

TL;DR

Evaxion A/S filed its July 6-K, confirming it's a foreign private issuer reporting under Form 20-F.

AI Summary

Evaxion A/S, a biotechnology company, filed a Form 6-K on July 25, 2025. This report is for the month of July 2025 and indicates that the company is a foreign private issuer filing its annual reports under Form 20-F. The company's principal executive office is located in Hoersholm, Denmark.

Why It Matters

This filing confirms Evaxion A/S's status as a foreign private issuer and its reporting schedule, which is important for investors tracking its regulatory compliance and financial disclosures.

Risk Assessment

Risk Level: low — This is a routine periodic filing that does not contain new material financial or operational information.

Key Players & Entities

  • Evaxion A/S (company) — Registrant
  • 20250725 (date) — Filing Date
  • Hoersholm, Denmark (location) — Principal Executive Office Location
  • Form 6-K (document) — Filing Type
  • Form 20-F (document) — Annual Report Form

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.

What is Evaxion A/S's filing status regarding annual reports?

Evaxion A/S indicates it files annual reports under cover of Form 20-F.

Where is Evaxion A/S's principal executive office located?

Evaxion A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.

What is the SEC file number for Evaxion A/S?

The SEC file number for Evaxion A/S is 001-39950.

When was the company formerly known as Evaxion Biotech A/S?

The company was formerly known as Evaxion Biotech A/S, with a date of name change on October 14, 2020.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 25, 2025 regarding Evaxion A/S (EVAX).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.